埃夫特(688165.SH):核心技術人員許禮進僅作為董事參與董事會決策,不再擔任公司任何職務
格隆匯3月1日丨埃夫特(688165.SH)公佈,公司核心技術人員許禮進因工作調整擔任蕪湖機器人產業發展集團有限公司董事長職務,申請辦理勞動關係轉移手續,並從公司正式離職。離職後,許禮進僅作為董事參與董事會決策,不再擔任公司任何職務。
2022年12月21日公司召開2022年第六次臨時股東大會、第三屆董事會第一次會議,會議選舉、聘用了公司新一屆董事會、高級管理人員,目前相關人員均正常履職,公司的技術研發和日常經營均正常進行,許禮進從公司離職,不會對公司的核心競爭力和持續經營能力產生實質性影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.